本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Artiva Biotherapeutics, Inc.

3.78
-0.0500-1.31%
盤後:3.820.0400+1.06%19:51 EST
成交量:177.54萬
成交額:680.51萬
市值:1.87億
市盈率:-1.35
高:3.93
開:3.82
低:3.77
收:3.83
52周最高:14.53
52周最低:2.96
股本:4,943.24萬
流通股本:1,987.84萬
量比:1.67
換手率:8.93%
股息:- -
股息率:- -
每股收益(TTM):-2.8001
每股收益(LYR):-3.4309
淨資產收益率:-43.61%
總資產收益率:-26.74%
市淨率:0.58
市盈率(LYR):-1.10

資料載入中...

2026/11/18

重要事件披露

Form 8-K - Current report
2026/11/10

重要事件披露

Form 8-K/A - Current report: [Amend]
2026/11/10

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/10/27

重要事件披露

Form 8-K - Current report
2026/10/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/09/11

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/09/11

重要事件披露

Form 8-K - Current report
2026/09/08

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/28

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/19

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/14

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/10

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/06

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/08/06

重要事件披露

Form 8-K - Current report
2026/07/22

重要事件披露

Form 8-K - Current report
2026/05/19

重要事件披露

Form 8-K - Current report
2026/05/18

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/18

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/18

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/18

關聯方擬減持公告

Form 144 - Report of proposed sale of securities